Biotage AB (Biotage AB) Equity-to-Asset

: 0.74 (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biotage AB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $356.5 Mil. Biotage AB's Total Assets for the quarter that ended in Dec. 2023 was $480.7 Mil. Therefore, Biotage AB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.74.

The historical rank and industry rank for Biotage AB's Equity-to-Asset or its related term are showing as below:

BITGF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.66 Med: 0.72 Max: 0.82
Current: 0.74

During the past 13 years, the highest Equity to Asset Ratio of Biotage AB was 0.82. The lowest was 0.66. And the median was 0.72.

BITGF's Equity-to-Asset is ranked better than
64.41% of 871 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs BITGF: 0.74

Biotage AB Equity-to-Asset Historical Data

The historical data trend for Biotage AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

0.66

0.69

0.70

0.74

Biotage AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Equity-to-Asset																0.70	0.72	0.75	0.74	0.74

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Biotage AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotage AB Equity-to-Asset Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Biotage AB's Equity-to-Asset falls into.

Biotage AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Biotage AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	356.516	/	480.717
	=	0.74

Biotage AB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	356.516	/	480.717
	=	0.74

Biotage AB (OTCPK:BITGF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Biotage AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Biotage AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (Biotage AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.